You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

16-1570

Showing 1 - 25 of 4,971
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Relapsed, Refractory Trial in New York (EGFRt/19-28z/4-1BBL CAR T cells)

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +2 more
  • EGFRt/19-28z/4-1BBL CAR T cells
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 1, 2022

Advanced Solid Tumors Trial in United States (ASP1570)

Recruiting
  • Advanced Solid Tumors
  • Fullerton, California
  • +10 more
Nov 18, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Lenvatinib, Pembrolizumab, Docetaxel)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Duarte, California
  • +87 more
Aug 18, 2022

Borderline Personality Disorder Trial in Lexington (Personality-Based Therapy)

Not yet recruiting
  • Borderline Personality Disorder
  • Personality-Based Therapy
  • Lexington, Kentucky
    Clinic for Emotional Health at the University of Kentucky
Aug 16, 2023

Breast Cancer Trial in Ankara (measurement of serum autotaxin serum level)

Completed
  • Breast Cancer
  • measurement of serum autotaxin serum level
  • Ankara, Turkey
    Ankara Etlik City Hospital
Jan 25, 2023

Mechanical Ventilation Pressure High, Intensive Care Unit Trial in China (invasive mechanical ventilation)

Recruiting
  • Mechanical Ventilation Pressure High
  • Intensive Care Unit
  • invasive mechanical ventilation
  • Peking, Beijing, China
  • +3 more
Jun 5, 2023

Pressure Recording Analytical Method Parameters in Hypertensive

Not yet recruiting
  • Cardiovascular Diseases
  • +4 more
  • Passive leg raising
  • İstanbul, Turkey
  • +1 more
Jul 17, 2023

Past Coronavirus Disease 19 Infection on Live Birth Rates of

Not yet recruiting
  • COVID-19
  • Frozen Embryo Transfer
  • frozen embryo transfer
  • Shanghai, China
    ShangHai JIAI Genetics&IVF Institute
Feb 21, 2023

Application of RCS in Pulmonary Rehabilitation

Recruiting
  • Respiratory Disease
    • Telese Terme, Benevento, Italy
    • +15 more
    Feb 17, 2023

    Nephrotic Syndrome in Children Trial in China (Adrenocorticotrophic Hormone, Steroid)

    Recruiting
    • Nephrotic Syndrome in Children
    • Wuhan, Hubei, China
    • +7 more
    Oct 8, 2023

    DLBCL, Not Otherwise Specified Trial in Chongqing (selinexor)

    Recruiting
    • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    Mar 27, 2023

    Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

    Recruiting
    • Core Binding Factor Acute Myeloid Leukemia
    • KIT Mutation-Related Tumors
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Apr 7, 2023

    Distracted Driving Trial in Philadelphia (Intervention, Control)

    Not yet recruiting
    • Distracted Driving
    • Intervention
    • Control
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Dec 6, 2022

    Infant Development Trial (Infant Formula)

    Not yet recruiting
    • Infant Development
    • Infant Formula
    • (no location specified)
    Jul 17, 2023

    Epilepsy, Intermittent Fasting Trial in Marburg (IF 16:8 as active comparator vs. IF MCT 16:8 as experimental arm)

    Recruiting
    • Epilepsy
    • Intermittent Fasting
    • IF 16:8 as active comparator vs. IF MCT 16:8 as experimental arm
    • Marburg, Hessen, Germany
      Philipps University Marburg, Faculty of Medicine, Department of
    Aug 24, 2023

    Amblyopia Trial in Columbus (Optical Correction, Therapeutic Dichoptic Virtual Reality Games)

    Recruiting
    • Amblyopia
    • Optical Correction
    • Therapeutic Dichoptic Virtual Reality Games
    • Columbus, Ohio
      The Ohio State University College of Optometry
    Sep 22, 2023

    Axial Spondyloarthritis Trial in Beijing (GR1501 low dose, GR1501 high dose, )

    Active, not recruiting
    • Axial Spondyloarthritis
    • GR1501 low dose
    • +2 more
    • Beijing, Beijing, China
      Peking union Medical Hosipital
    May 21, 2023

    T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)

    Not yet recruiting
    • T Cell Lymphoma
    • New Haven, Connecticut
      Yale Smilow Cancer Hospital
    Aug 14, 2023

    Ankle Fractures Trial in Columbia (Postoperative protocol (Immediate weight bearing), Postoperative Protocol (Delayed Weight

    Recruiting
    • Ankle Fractures
    • Postoperative protocol (Immediate weight bearing)
    • Postoperative Protocol (Delayed Weight Bearing)
    • Columbia, Missouri
      University of Missouri Health System
    Nov 16, 2022

    Breast Cancer, Colorectal Cancer, Prostate Cancer Trial in Boston (Supervised Home-Based Exercise, Unsupervised Home-Based

    Recruiting
    • Breast Cancer
    • +2 more
    • Supervised Home-Based Exercise
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2022

    Suture Trial in Hong Kong (Virtual reality)

    Recruiting
    • Suture
    • Virtual reality
    • Hong Kong, Hong Kong
      Tuen Mun Hospital-Emergency department
    Mar 21, 2023

    Heart Failure, Left Ventricular Systolic Dysfunction Trial (Vericiguat tablet, Vericiguat suspension, Placebo tablet)

    Not yet recruiting
    • Heart Failure
    • Left Ventricular Systolic Dysfunction
    • Vericiguat tablet
    • +3 more
    • (no location specified)
    Jan 26, 2023

    Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)

    Not yet recruiting
    • Pulmonary Sarcoidosis
    • XTMAB-16 or Placebo
    • (no location specified)
    May 25, 2023

    Moderate-to-severe Plaque Psoriasis Patients Response to

    Completed
    • Moderate-to-severe Plaque Psoriasis
      • Jakarta, Indonesia
        Mangga Besar Clinic
      Mar 15, 2023

      Atopic Dermatitis Trial in Canada, United States (Tralokinumab, Placebo, Tdap vaccine)

      Completed
      Has Results
      • Atopic Dermatitis
      • Fort Smith, Arkansas
      • +50 more
      Oct 14, 2022